Cancer in organ transplanted patients;Kreft hos organtransplanterte pasienter

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 25, 1999, Pages 3792-3794

  Pfeffer, Per F ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

HUMAN; IMMUNOLOGY; NEOPLASM; ORGAN TRANSPLANTATION; REVIEW; RISK FACTOR; VIRUS INFECTION;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEOPLASMS; ORGAN TRANSPLANTATION; RISK FACTORS; VIRUS DISEASES;

EID: 0033589166     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bergan S, Albrechtsen D, Bentdal Ø. Immunsuppressive medikamenter ved organtransplantasjon. Tidsskr Nor Lægeforen 1999; 119: 3615-20.
2. Midtvedt K. Infeksjoner hos nyretransplanterte pasienter i Norge. Tidsskr Nor Lægeforen 1999; 119: 3621-3.
3. Hjelmesæth J, Midtvedt K, Aakhus S, Hartmann A. Kardiovaskulær sykdom etter nyretransplantasjon. Tidsskr Nor Lægeforen 1999; 119: 3784-8.
4. Sheil AGR. Development of malignancy Following renal transplantation in Australia and New Zealand. Transplant Proc 1992; 24: 1275-9.
5. Pfeffer PF, Leivestad T, Albrechtsen D, Fauchald P. Brekke IB. Anamnestic cancer: how long should the cancer-free interval be before renal transplantation? Transplant Proc 1997; 29: 3163.
6. Penn I, Brunson ME. Cancer after cyclosporine therapy. Transplant Proc 1988; 20: 885.
7. Manson ADC, Landsberg DN. Prostatic carcinoma following renal transplantation. Transplant Proc 1989; 21: 3313-4.
8. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. I: Terasaki PI, Cecka JM. Clinical transplants 1994. Los Angeles, CA: UCLA Tissue Typing Laboratory, 99-109.
9. Baquero A, Penn l, Bannett A, Werner DJ, Kim P. Misdiagnosis of metastatic cerebral choriocarcinoma in female cadaver donors. Transplant Proc 1988; 20: 776-7.
10. Penn J. Transmission of cancer from organ donors. Ann Transpl 1997; 2: 7-12.
11. Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O et al. Skin cancer in kidney and heart transplant recipients and different longterm immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
12. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme L Forsberg B et al. Cancer risk after renal transplantation in the Nordic countries 1964-1986. Int J Cancer 1995; 60: 183-9.
13. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in transplant patients. Lancet 1995; 346: 403-6.
14. Kyllonen L, Pukkala E, Eklund B. Cancer incidence in a kidney-transplant population. Transpl Int 1994; 7: 350-2.
15. Calne RY, Rolles K, White DJG, Thiru S, Evans DB, McMaster P et al. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases and 2 livers. Lancet 1979; 2: 1033-6.
16. Touraine JL, Garnier JL, Lefrançois N, Finaz de Villaine J, Dubernard JM, de The G et al. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients. Transplant Proc 1989; 21: 3197-8.
17. Opelz G, Henderson R. The Collaborative Transplant Registry. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-6.
18. Birkeland SA. Malignancies occuring de novo after transplantation. Current Opinion Organ Transplant 1998; 3: 82-9.
19. Morris JDH, Eddleston ALW, Crook T. Viral infection and cancer. Lancet 1995; 346: 754-8.
20. Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol 1998; 16: 330-7.
21. Cathomas G, Tamm M, McGandy CE, Itin PH, Gudat F, Thiel G et al. Transplantation-associated malignancies: restriction of human herpes virus 8 to Kaposi's sarcoma. Transplantation 1997; 64: 175-8.